Nicotine & Cotinine
NIC / COT
Primary Products
DrugSURE® Integrated Test Cups
DrugSURE® Dip Tests
OralTox® Oral Fluid Tests
What is Nicotine & Cotinine?
Nicotine is a highly addictive stimulant naturally found in tobacco plants and commonly consumed through cigarettes, cigars, vaping devices, and smokeless tobacco. Once absorbed, the body rapidly metabolizes nicotine into cotinine, a stable and longer-lasting biomarker used in toxicology testing. Cotinine is preferred for screening because it remains in the system longer and provides a more accurate indication of recent nicotine exposure.
-
Nicotine appears in tobacco products (leafy material), vape liquids (clear to colored fluids), patches, gums, and lozenges formulated for cessation.
-
Cotinine is not a drug or consumable substance—it’s a metabolite detected in biological samples (urine, saliva, blood) for screening purposes.
Nicotine is typically inhaled through smoking or vaping, or absorbed through oral or dermal products like chew, gum, or patches.
-
Medical/therapeutic uses: Nicotine replacement therapies (NRT) such as gum, lozenges, and patches are FDA-approved to help smokers quit by delivering controlled, lower doses of nicotine.
-
Recreational use: Smoking, vaping, or using smokeless tobacco products for stimulation, stress relief, or habit, often leading to dependence. Vaping has significantly increased nicotine exposure among young adults and teens.
Effects:
-
Increased alertness and mild stimulation
-
Elevated heart rate and blood pressure
-
Relaxation or stress relief due to dopamine release
-
Reduced appetite
-
Dizziness or nausea (especially in new users)
-
Headaches
-
Withdrawal symptoms such as irritability and cravings
-
Increased risk of cardiovascular disease with chronic use
-
Reduced lung function and respiratory symptoms from smoking/vaping
-
High addiction potential and difficulty quitting
Commons Slang Terms:
-
Smokes
-
Cigs
-
Vapes
-
Dip
-
Chew
-
Stogies
-
Juuls
-
Nic
-
Snus
-
Analog cigarettes (industry slang contrasting with e-cigs)
Legal Status:
Nicotine itself is legal for adult use in the United States but regulated by the FDA, particularly in products like cigarettes, cigars, e-cigs, and nicotine replacement therapies. Because nicotine is legal, testing programs generally do not screen for it to enforce abstinence—except in specific contexts such as insurance qualification, smoking cessation monitoring, pre-surgical requirements, athletic programs, or workplaces that enforce non-tobacco hiring policies.
In point-of-care rapid testing programs, cotinine is the biomarker screened to determine recent nicotine use. Cotinine’s longer detection window (typically 2–4 days, sometimes longer for heavy users) makes it a reliable indicator of tobacco or vaping exposure. Organizations using cotinine testing must clearly define why they test (e.g., insurance incentives, wellness programs, abstinence verification) because the detection of nicotine is not tied to impairment, only exposure. Policies must also outline how therapeutic nicotine replacement products are handled, since these can also produce positive results.
Screening Options:
LEGEND
GET STARTED
Speak with one of our expert consultants today!
Email Us
info@ntsbiz.com
Phone
1-866-989-9300
Address
550 NW 5th St.
Boca Raton, FL 33486
Monday - Friday
8am - 5pm




